Skip to main content

Table 1 Sociodemographic and clinical characteristics of respondents, SA-PCCOC registry (2010–2019)

From: Patient-reported functional outcome measures and treatment choice for prostate cancer

Variable

Treatment type

 
 

RP (n = 2810)

EBRT (n = 1011)

Brachytherapy (n = 343)

AS (n = 762)

p-value

 

No.

%

No.

%

No.

%

No.

%

Age, mean (sd)

64.5 (6.9)

71.9 (7.2)

65.7 (7.0)

64.8 (7.7)

 

Below 60

636

22.6

52

5.1

70

20.4

202

26.5

< 0.001

60–64

639

22.7

110

10.9

70

20.4

135

17.7

 

65–70

969

34.5

229

22.7

113

32.9

247

32.4

 

Above 70

566

20.1

620

61.3

90

26.2

178

23.4

 

Risk category

         

Low

423

15.1

67

6.6

66

19.2

581

76.2

< 0.001

Intermediate

1442

51.3

339

33.5

185

53.9

77

10.1

 

High

865

30.8

578

57.2

66

19.2

8

1.0

 

Missing

80

2.8

27

2.7

26

7.6

96

12.6

 

SEIFA

         

Lowest

494

17.6

260

25.7

81

23.6

145

19.0

< 0.001

Low

434

15.4

214

21.2

71

20.7

139

18.2

 

Medium

473

16.8

183

18.1

68

19.8

120

15.7

 

High

668

23.8

180

17.8

72

21.0

196

25.7

 

Highest

511

18.2

92

9.1

33

9.6

94

12.3

 

Missing

230

8.2

82

8.1

18

5.2

68

8.9

 

Diagnostic PSA level (ng/mL)

        

<4

287

10.2

56

5.5

31

9.0

160

21.0

< 0.001

4–10

1705

60.7

388

38.4

214

62.4

461

60.5

 

10–20

463

16.5

266

26.3

37

10.8

46

6.0

 

>20

98

3.5

163

16.1

6

1.7

5

0.7

 

Missing

257

9.1

138

13.6

55

16.0

90

11.8

 

Gleason score

         

<=6

594

21.1

112

11.1

93

27.1

714

93.7

< 0.001

3 + 4

1086

38.6

285

28.2

140

40.8

32

4.2

 

4 + 3

604

21.5

206

20.4

69

20.1

1

0.1

 

8

299

10.6

184

18.2

26

7.6

0

0.0

 

9–10

204

7.3

204

20.2

10

2.9

0

0.0

 

Missing

23

0.8

20

2.0

5

1.5

15

2.0

 

Primary symptoms#

         

Elevated PSA

2316

82.4

779

77.1

278

81.0

533

69.9

< 0.001

LUTS

76

2.7

78

7.7

8

2.3

96

12.6

 

Other

52

1.9

25

2.5

9

2.6

28

3.7

 

Missing

366

13.0

129

12.7

48

14.0

105

13.8

 
  1. RP, radical prostatectomy; EBRT, external beam radiation therapy; AS, active surveillance
  2. sd, standard deviation; SEIFA, socio-economic indexes for areas; PSA, prostate-specific antigen; LUTS, lower urinary tract symptoms
  3. #Erectile dysfunction (n = 3) was re-grouped under other